[On the mechanism of radioprotective effect of NO-synthase inhibitors]

Insights

Selective inhibition of endothelial nitric oxide synthase (NOS) induces hypoxia, conferring radioprotective effects. This suggests potential for developing new radioprotectors targeting endothelial NOS.

Area of Science:

  • Pharmacology
  • Radioprotection
  • Physiology

Context:

  • Nitric oxide synthase (NOS) inhibitors are explored for radioprotective potential.
  • Understanding NOS isoform selectivity is crucial for predicting therapeutic effects.
  • Hemodynamic responses to NOS inhibition vary based on isoform selectivity.

Purpose:

  • To investigate the hemodynamic and radioprotective effects of two isothiourea derivatives with differing NOS isoform selectivity.
  • To determine the role of NOS isoform selectivity in mediating radioprotection.
  • To elucidate the mechanism underlying the radioprotective activity of NOS inhibitors.

Summary:

  • T1023, an endothelial and inducible NOS inhibitor, induced prolonged hypotension and significant reduction in systemic blood flow, creating hypoxic conditions.
  • NTT2, a neuronal NOS inhibitor, caused vasodilation and maintained systemic blood flow.
  • T1023 demonstrated significant radioprotective effects in mice and bone marrow stem cells, while NTT2 did not.
  • Radioprotection by NOS inhibitors appears to be mediated by hypoxia induction, particularly via endothelial NOS suppression.

Impact:

  • The findings support hypoxia induction as the primary mechanism for radioprotection by NOS inhibitors.
  • Selective inhibition of endothelial NOS is identified as a key factor for effective radioprotective activity.
  • This research provides a basis for designing novel radioprotectors targeting endothelial NOS for radiation therapy and exposure mitigation.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.9K
2° Amines to N-Nitrosamines: Reaction with NaNO201:20

2° Amines to N-Nitrosamines: Reaction with NaNO2

Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
5.9K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
2.0K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.5K
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H01:13

meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H

All meta-directing substituents are deactivating groups. These substituents withdraw electrons from the aromatic ring, making the ring less reactive toward electrophilic substitution. For example, the nitration of nitrobenzene is 100,000 times slower than that of benzene because of the deactivating effect of the nitro group. The first step in an electrophilic aromatic substitution is the addition of an electrophile to form a resonance-stabilized carbocation. The energy diagrams for...
7.1K
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
134